Form 8-K - Current report:
SEC Accession No. 0001367644-16-000057
Filing Date
2016-02-25
Accepted
2016-02-25 16:27:43
Documents
2
Period of Report
2016-02-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8kearningsq42015.htm 8-K 15022
2 ex-99_q42015.htm EX-99 433004
  Complete submission text file 0001367644-16-000057.txt   449148
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 161456305
SIC: 2834 Pharmaceutical Preparations